Pfizer : PFE

All Pfizer Articles

1482 Articles

Chris Lange | May 1, 2017 at 11:30 AM EDT

What to Expect From Apple and More Dow Stocks Reporting on Tuesday

24/7 Wall St. has put together a preview of the Dow Jones Industrial Average companies scheduled to report their quarterly…

Chris Lange | Apr 30, 2017 at 9:25 AM EDT

Facebook, Tesla and More Major Earnings Coming Out This Week

24/7 Wall St. has put together a preview of Apple, Facebook, Pfizer and some of the other top companies reporting…

Chris Lange | Apr 26, 2017 at 8:25 AM EDT

Short Sellers Can’t Make Up Their Minds on Major Pharma

The April 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Apr 12, 2017 at 8:25 AM EDT

Short Sellers Run for Cover From Major Pharma Stocks

The March 31 short interest data have been compared with the previous figures, and short interest decreased in most of…

Paul Ausick | Apr 11, 2017 at 4:01 PM EDT

Apple, DuPont Sink DJIA Tuesday

Apple, DuPont, Goldman Sachs, and Pfizer led the DJIA to a lower close on Tuesday.

Chris Lange | Mar 27, 2017 at 8:35 AM EDT

Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote

The March 15 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Mar 27, 2017 at 6:50 AM EDT

The 6 Most Shorted NYSE Stocks

With the major markets retreating from all-time highs, it began to look like the Trump rally was spent. Judging by…

Chris Lange | Mar 25, 2017 at 9:15 AM EDT

How Health Care Stocks Responded to the Shelved Health Care Bill

24/7 Wall St. has taken a look at a few companies within the health care sector that might have seen…

Paul Ausick | Mar 24, 2017 at 4:01 PM EDT

DuPont, Boeing Sink DJIA Friday

Goldman Sachs, DuPont, Boeing, and Pfizer weighed on the Dow Jones Industrial Average Friday.

Paul Ausick | Mar 16, 2017 at 4:05 PM EDT

DuPont, Chevron Take DJIA Down Thursday

DuPont, Chevron, Merck, and Pfizer sink the DJIA on Thursday.

Chris Lange | Mar 10, 2017 at 8:55 AM EST

Short Sellers Back Off Major Pharma

The February 28 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Mar 10, 2017 at 6:10 AM EST

The 6 Most Shorted NYSE Stocks

The bull market is now eight years old, and markets still keep on hitting new highs. How have the short…

Paul Ausick | Mar 7, 2017 at 4:01 PM EST

Chevron, Verizon Sink DJIA on Tuesday

Chevron, Verizon, Pfizer, and Merck combined to weigh on the DJIA Tuesday.

Chris Lange | Mar 6, 2017 at 9:50 AM EST

Where Merck and Pfizer’s Type 2 Diabetes Treatment Can Go From Here

Merck and Pfizer each saw their shares sink early on Monday after the firms gave an update on their type…

Chris Lange | Feb 28, 2017 at 8:55 AM EST

Why Short Sellers Are Making a Massive Bet in Major Pharma

Judging by this report, short sellers are making a tremendous bet against Trump’s plan to reform the health care sector.

1 … 41 42 43 44 45 … 99

Pfizer : PFE

All Pfizer Articles

What to Expect From Apple and More Dow Stocks Reporting on Tuesday

Facebook, Tesla and More Major Earnings Coming Out This Week

Short Sellers Can’t Make Up Their Minds on Major Pharma

Short Sellers Run for Cover From Major Pharma Stocks

Apple, DuPont Sink DJIA Tuesday

Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote

The 6 Most Shorted NYSE Stocks

How Health Care Stocks Responded to the Shelved Health Care Bill

DuPont, Boeing Sink DJIA Friday

DuPont, Chevron Take DJIA Down Thursday

Short Sellers Back Off Major Pharma

The 6 Most Shorted NYSE Stocks

Chevron, Verizon Sink DJIA on Tuesday

Where Merck and Pfizer’s Type 2 Diabetes Treatment Can Go From Here

Why Short Sellers Are Making a Massive Bet in Major Pharma

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

Most Income Investors Have Never Heard of These 3 ETFs Paying Over 10 Percent Monthly

The Home Sale That Adds $5,880 a Year to a Retiree’s Medicare Premium Two Years Later

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

The Home Sale That Adds $5,880 a Year to a Retiree's Medicare Premium Two Years Later

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

Most Income Investors Have Never Heard of These 3 ETFs Paying Over 10 Percent Monthly

Pfizer : PFE

All Pfizer Articles

What to Expect From Apple and More Dow Stocks Reporting on Tuesday

Facebook, Tesla and More Major Earnings Coming Out This Week

Short Sellers Can’t Make Up Their Minds on Major Pharma

Short Sellers Run for Cover From Major Pharma Stocks

Apple, DuPont Sink DJIA Tuesday

Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote

The 6 Most Shorted NYSE Stocks

How Health Care Stocks Responded to the Shelved Health Care Bill

DuPont, Boeing Sink DJIA Friday

DuPont, Chevron Take DJIA Down Thursday

Short Sellers Back Off Major Pharma

The 6 Most Shorted NYSE Stocks

Chevron, Verizon Sink DJIA on Tuesday

Where Merck and Pfizer’s Type 2 Diabetes Treatment Can Go From Here

Why Short Sellers Are Making a Massive Bet in Major Pharma

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

Most Income Investors Have Never Heard of These 3 ETFs Paying Over 10 Percent Monthly

The Home Sale That Adds $5,880 a Year to a Retiree’s Medicare Premium Two Years Later

Featured Reads

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

The Home Sale That Adds $5,880 a Year to a Retiree's Medicare Premium Two Years Later